We have advised Global Bioenergies on its capital increase for €17m. The subscribers to this capital increase include CM-CIC and the investment fund BOLD of the L’Oréal Group.
Founded in 2008, listed on Euronext Growth since 2011 and headquartered close to Paris, France, Global Bioenergies has developed a unique process to convert renewable resources into bio-based isobutene. Isobutene and its derivatives are hydrocarbons currently extracted from fossil oil, representing a $20bn market, with a broad range of uses in cosmetics, replacement of volatile silicones, which are progressively phased out, and fuels such as speciality fuels, jet fuel, and drop-in gasoline.
Having developed a strong IP portfolio, Global Bioenergies aims to deploy the technology worldwide.
Funding will allow the company to complete the development of its isobutene process at laboratory, pilot and demo scale, as well as continue its R&D efforts to adapt its process to the use of second and third-generation resources, participate to the financing of the front-end engineering design phase of the first plant as conducted by IBN-One, and support IBN-One in its fundraising efforts to start the construction of the plant.
